PATENT CLAIM ANALYSIS

Application Number: 16082753
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["514", "386000"]

Abstract:
A compound of Formula I: or pharmaceutically acceptable enantiomers, or salts thereof. The present invention also relates to the use of compounds of Formula (I) as selective inhibitors of indoleamine 2,3-dioxygenase. The invention also relates to the use of the compounds of Formula (I) for the treatment or prevention of diseases cancer, infections, central nervous system disease or disorder, and immune-related disorders, either as a single agent or in combination with other therapies.

Claim (Index 15):
The compound or the pharmaceutically acceptable salt thereof according to claim  1 , wherein the compound or the pharmaceutically acceptable salt thereof has an inhibitory potency on indoleamine 2,3-dioxygenase (IDO1) with an IC 50  of 25 \u03bcM or less.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 97.0
- Lexical Diversity: 1.62264
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15128874', '12265091', '16317245', '13393767', '15748557']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8116583191062248
- 35 USC 102 Novelty (BERT): 0.5427002230705792
- Combined Prediction Score: 0.7847625095026602
- Mean Citation Score: 347.380348
- Max Citation Score: 396.0309
- Similarity Product: 287.89090547407864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test